The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Weekend Unlimited Inc. is capitalizing on vast industry relationships to establish a portfolio of cannabis brands throughout North America and internationally. Weekend Unlimited’s brand portfolio includes geographic footholds in California, Washington State, British Columbia and Las Vegas, establishing a strong, versatile foundation for substantial growth. The product portfolio will be focused under the headings of flower, edibles and extracts.
Wildflower is a holistic wellness company headquartered in Vancouver building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts.
Willow Biosciences are pioneers in the biotechnology sector and have developed the only fully-integrated synthetic biology solution for opioid biosynthesis. We are now leveraging our unique design-build process to the biosynthesis of cannabinoids.
The Issuer provides precision single step production mobile extraction systems. Using patent-pending technologies, it produces higher yields of full spectrum cannabis oil at faster rates. Its technology was influenced by the petroleum processing industry. This technology is designed to be an industrial scalable continuous flow process that can use both wet and dry cannabis/hemp as inputs.
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Additional information on XORTX Therapeutics is available at www.XORTX.com.